Literature DB >> 29179244

Is Ovarian Cancer Prevention Currently Still a recommendation of Our Grandparents?

Millena Prata Jammal1, Cid Almeida de Lima1, Eddie Fernando Candido Murta1, Rosekeila Simões Nomelini1.   

Abstract

Ovarian cancer is the leading cause of death among gynecologic tumors because in most of the cases (75%), the disease is diagnosed in advanced stages. Screening methods are not available since the disease is rare, and the tested methods, such as ultrasound and CA125, were not able to decrease the mortality rate for this type of cancer. This article discusses the main risk factors for ovarian cancer, and the potential clinical and surgical strategies for the prevention of this disease. Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil.

Entities:  

Mesh:

Year:  2017        PMID: 29179244     DOI: 10.1055/s-0037-1608867

Source DB:  PubMed          Journal:  Rev Bras Ginecol Obstet        ISSN: 0100-7203


  2 in total

1.  Roflumilast enhances cisplatin-sensitivity and reverses cisplatin-resistance of ovarian cancer cells via cAMP/PKA/CREB-FtMt signalling axis.

Authors:  Shipeng Gong; Yongning Chen; Fanliang Meng; Yadi Zhang; Chanyuan Li; Guangping Zhang; Wu Huan; Fei Wu
Journal:  Cell Prolif       Date:  2018-08-02       Impact factor: 6.831

2.  Lifestyle and reproductive health: the aetiology of ovarian cancer in Pakistan.

Authors:  Qurratulann Alvi; Gul Muhammad Baloch; Karuthan Chinna; Ali Dabbagh
Journal:  F1000Res       Date:  2020-08-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.